Michael Guest bought Johnson & Johnson (NYSE: JNJ)
Michael Guest (R-MS), a U.S. Representative, has disclosed 1 trade in Johnson & Johnson (JNJ) since 2023, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Michael Guest bought $1,001 - $15,000 of Johnson & Johnson (NYSE: JNJ) on August 7, 2023. Since that trade, JNJ is up +67.45% against the S&P 500 up +67.57%, an outperformance of -0.12%.
Data updated
Michael Guest's JNJ trades vs the price
JNJ is up +67.45% since Michael Guest bought on August 7, 2023, versus +67.57% for the S&P 500.
Performance since this trade
All Michael Guest JNJ trades
Michael Guest & JNJ trading FAQ
Is it legal for Michael Guest to trade Johnson & Johnson (JNJ) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Johnson & Johnson (JNJ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael Guest buy JNJ?
Michael Guest disclosed a purchase of $1,001 - $15,000 of Johnson & Johnson (JNJ) on August 7, 2023, according to public STOCK Act filings.
How has JNJ performed since Michael Guest's trade?
Since Michael Guest bought JNJ on August 7, 2023, the stock is up +67.45%, versus +67.57% for the S&P 500 over the same period, an outperformance of -0.12%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JNJ trades?
Quantellect tracks every disclosed congressional trade in Johnson & Johnson (JNJ) on the Johnson & Johnson congressional trading page, which aggregates filings across all members of Congress.
Michael Guest's JNJ tradesAll congressional filings for Johnson & JohnsonMichael Guest's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.